Wednesday, November 6, 2024

AI Powerhouse Sees 853% Increase From Connecticut Billionaire

Follow the Ivy at SummayMoney.com

Friday, November 6th 2024

AI Powerhouse Sees 853% Increase From Connecticut Billionaire

Nvidia (NASDAQ: NVDA) has rapidly cemented its place as one of the most sought-after stocks after seizing the role of toll road through which all big tech must travel to enter the artificial intelligence ecosystem.

 

Get the full details here

Sponsored
2024's Must-Watch Stocks!
Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips.   Learn More
Privacy Policy/Disclosures

Ivy Content you May Have Missed

The Magnificent 7 Have a New Trillion Dollar Rival

Berkshire Hathaway (NYSE:BRK.B) is arguably one of the most successful companies in American history. The conglomerate founded by Warren Buffett now owns stakes in both large public companies and several wholly-owned subsidiaries.

 

Get the full details here

Sponsored
Curious About AI's Next Big Winners?
Unlock invaluable investment secrets and peer into the future of the AI sector. This report is your indispensable guide, whether you're a seasoned pro or someone looking to master the AI realm. Learn More
Privacy Policy/Disclosures

Is Shopify a Slam Dunk Buy on the Dip?

Recently, an under-the-radar tech company has captured the interest of top-tier investment funds. Hedge funds have quietly been acquiring significant shares that displays a conviction in this company's potential to redefine its market.

 

Get the full details here

Sponsored
Bitcoin, Ethereum, or Ripple? See Our Top Crypto Pick for 2024!
Which one will lead the pack in 2024? Our comprehensive report dives deep into market analyses, upcoming trends, and regulatory impacts that will define the next big crypto winner. Learn More
Privacy Policy/Disclosures

1 Titan Health Stock Is Way Too Cheap

Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven't been enough to get shareholders excited as the share price has fallen under water this year, down 6%.

 

Get the full details here

- G. O'Fiachra

 

The Ivy by Summa Money | World Class Investing

 

We value your feedback: Please let us know what you think about our investing ideas so far, and any recommendations you may have for increasing the value of this newsletter. Please follow this link for a quick, 2-minute survey

You Might Also Like:

Follow the Burst at SummayMoney.com

Advertising Disclosure: This email may contain paid advertisements.

Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world.

We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive.

If you do not want to receive emails from us, you can follow this link to unsubscribe. or click the unsubscribe link at the bottom of the email that you do not want to receive.

If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com.

Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here.

If you can't see this message, view it in your browser.

You are receiving this e-mail at edwardlorilla1986.paxforex@blogger.com as a part of your free subscription to the Ivy Newsletter.

To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe.

To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311

Website: Summa Money

Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice.

Copyright 2024 Summa Money. All rights reserved.

If you do not want to receive emails from us, you can follow this link to unsubscribe. FROM THE IVY NEWSLETTER

Advertise With Us


In order to unsubscribe from this mailing list, please click here

No comments:

Post a Comment

Why are these companies are BEGGING to pay you?

Take a look at this payment that came in…                               See this $1,109 payment on the screen (starting stake of $25,400...